Established in 2018 and headquartered at Singapore, MEDO.ai combines ultrasound diagonisis technology with artificial intelligence on medical services. They applies these techniques to provde on-the-spot diagnosis of ultrasound images to any clinician at point-of-care of a patient.
| Company Name | Medo.ai |
|---|---|
| Brand Name | Medo.ai |
| Industries | AI Healthcare Software |
| Year of Establishment | 2018 |
| Founder(s) | Jacob L. Jaremko |
| No. of Employees | 11 to 50 |
| Regional Coverage | Singapore |
| Clients | / |
| Stage | Seed |
| Investor(s) | Wavemaker Partners SGInnovate Entrepreneur First |
| Fundraising History | Undisclosed Amount (Sep 2018) Undisclosed Amount (Jan 2018) |
| Raising Fund | / |
| Fundraising target | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Media Exposure | CNBC |
| Company Email | [email protected] |
[dcb id=160440]